ENGINZYME AB Biocatalyst CPS Silica Patent US12606812B2

USPTO granted ENGINZYME AB patent US12606812B2 for a biocatalyst composition comprising controlled porosity silica (CPS) as support material with pore diameters between 20 and 100 nm, an amino-functionalized surface, and immobilized catalytically active enzymes. The patent also covers methods of manufacturing such biocatalysts and uses thereof in organic synthesis. The patent contains 3 claims and was granted on April 21, 2026, with an application date of November 19, 2024.

Biotechnology and pharmaceutical manufacturers developing enzyme-based processes for organic synthesis should review this patent when considering enzyme immobilization technologies using porous silica supports in the specified pore size range. The patent may be relevant to companies engaged in biocatalysis research, enzyme engineering, or sustainable manufacturing processes. COMP entry via CPC classifications C12N 11/14, C12N 9/20, C12N 11/06, and C12Y 301/01003 indicates applicability to enzyme immobilization and lipase-based biocatalytic processes.